GUJARAT THEMIS BIOSYN
Back to Cashflow Statement
|
GUJARAT THEMIS BIOSYN Last 5 Year Net Cash Inflow / Outflow History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹5.22 Cr | ₹0.41 Cr | ₹5.79 Cr | ₹-3.51 Cr | ₹3.12 Cr |
What is the latest Net Cash Inflow / Outflow ratio of GUJARAT THEMIS BIOSYN ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹5.22 Cr |
| Mar2024 | ₹0.41 Cr |
| Mar2023 | ₹5.79 Cr |
| Mar2022 | ₹-3.51 Cr |
| Mar2021 | ₹3.12 Cr |
How is Net Cash Inflow / Outflow of GUJARAT THEMIS BIOSYN Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹5.22 Cr | 1,162.08 | |
| Mar2024 | ₹0.41 Cr | -92.85 | |
| Mar2023 | ₹5.79 Cr | Positive | |
| Mar2022 | ₹-3.51 Cr | Negative | |
| Mar2021 | ₹3.12 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of GUJARAT THEMIS BIOSYN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GUJARAT THEMIS BIOSYN | ₹3,567.6 Cr | 4.5% | 3.8% | 32.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹411,054.0 Cr | 0.9% | 6.2% | -1.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,075.0 Cr | 2% | 4.8% | 4.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,904.0 Cr | 3.6% | 6% | 36.9% | Stock Analytics | |
| CIPLA | ₹107,358.0 Cr | -0.1% | -3% | -8.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,813.0 Cr | 1% | 10.8% | 4.7% | Stock Analytics | |
GUJARAT THEMIS BIOSYN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GUJARAT THEMIS BIOSYN | 4.5% |
3.8% |
32.2% |
| SENSEX | -1.4% |
0.4% |
8.3% |
You may also like the below Video Courses